News|Articles|October 3, 2026

8 Pulmonology Headlines You Missed in Q3 2026

Fact checked by: Abigail Brooks, MA

Catch up on key FDA approvals, major trial updates, and critical clinician insights from the last 3 months.

Pulmonology has seen significant growth over the past few months, with the acceptance of major New Drug Applications by the US Food and Drug Administration (FDA) and a series of major conferences around the world. With so much new data and so many major headlines published over the last 3 months, the HCPLive editorial team has compiled 8 of the most impactful stories from the third quarter of 2026. As we move into the fourth and final quarter of the year, catch up on anything you may have missed below:

Related to this article